Skip to main content

Adlai Nortye Group Ltd.

ANL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001944552

In the last 90 days, Adlai Nortye Group Ltd. insiders filed 0 open-market purchases and 2 sales; 42 institutions reported holding it in 13F filings for Q2 2026, worth $304.3M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Adlai Nortye Group Ltd. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
2 filings
2 insiders, $247.8K in total
Insiders trading
2
Net value
−$247.8K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Adlai Nortye Group Ltd., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Adlai Nortye Group Ltd.
NameTitleLast reported holdingLast filingFilings, past year
Ji PingDirector131,667Sep 24, 20262
Ye XiaofengCFO147,757Aug 26, 20261
Lu YangCEO99,990May 21, 20261

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 24, 2026 (view filing)11:07 AM ETSep 222 daysJi PingDirectorSSaleAmerican Depository shares−5.00K$16.63−$83.2K−3.7%131.7K after
Aug 26, 2026 (view filing)4:28 PM ETAug 24-262 daysYe XiaofengCFOSSaleAmerican Depositary Shares−11.7K$14.11−$164.6K−7.3%147.8K after2 lots
May 21, 2026 (view filing)May 138 daysLateLu YangCEOSSaleAmerican Depositary Shares−10$13.18−$131.80.0%100.0K after